scholarly journals Global Cardiovascular Risk Profile of Italian Medical Students Assessed by a QR Code Survey. Data from UNIMI HEART SURVEY: Does Studying Medicine Hurt?

2021 ◽  
Vol 10 (7) ◽  
pp. 1343
Author(s):  
Andrea Faggiano ◽  
Francesca Bursi ◽  
Gloria Santangelo ◽  
Cesare Tomasi ◽  
Chiarella Sforza ◽  
...  

Background: Few studies to date have addressed global cardiovascular (CV) risk profile in a “protected” young population as that of medical school students. Objective: to assess CV traditional risk factors and global CV risk profile of Italian medical students throughout the six years of university. Methods: A cross-sectional survey accessible online via quick response (QR) code was conducted among 2700 medical students at the University of Milan, Italy. Data on baseline characteristics, traditional CV risk factors, diet, lifestyle habits, and perceived lifestyle variations were evaluated across different years of school. Results: Overall, 1183 students (mean age, 22.05 years; 729 women (61.6%)) out of 2700 completed the questionnaire (43.8% rate response). More than 16% of the students had at least 3 out of 12 CV risk factors and only 4.6% had ideal cardiovascular health as defined by the American Heart Association. Overweight, underweight, physical inactivity, sub-optimal diet, smoke history, and elevated stress were commonly reported. Awareness of own blood pressure and lipid profile increased over the academic years as well as the number of high-blood-pressure subjects, alcohol abusers, and students constantly stressed for university reasons. Moreover, a reduction in physical-activity levels over the years was reported by half of the students. Conclusion and Relevance: This study demonstrates that a “protected” population as that of young medical students can show an unsatisfactory cardiovascular risk profile and suggests that medical school itself, being demanding and stressful, may have a role in worsening of the lifestyle.

2000 ◽  
Vol 45 (3) ◽  
pp. 84-85 ◽  
Author(s):  
S.R. McEwan ◽  
N.G. Dewhurst ◽  
F. Daly ◽  
C.D. Forbes ◽  
J.J.F. Belch

Summary analyses of screening data were used to ascertain the cardiovascular risk profile in a sample of health care workers in Scotland. A sample of NHS staff (298 women and 78 men) were screened during visits to Perth Royal Infirmary (PRI) in 1996 and 1997. Comparisons were made within subsets and with previous screening studies. Health care workers have been a neglected component of the workforce for receiving education about risk factors. The high prevalence of smokers found in this sample should be a cause for concern.


2021 ◽  
Vol 131 (10) ◽  
Author(s):  
Andrzej Januszewicz ◽  
Wiktoria Wojciechowska ◽  
Aleksander Prejbisz ◽  
Piotr Dobrowolski ◽  
Marek Rajzer ◽  
...  

2014 ◽  
pp. 97-111
Author(s):  
Michele Bombelli ◽  
Rita Facchetti ◽  
Gianmaria Brambilla ◽  
Guido Grassi ◽  
Giuseppe Mancia

2014 ◽  
Vol 33 (9) ◽  
pp. 525-534 ◽  
Author(s):  
Teresa Rocha ◽  
Evangelista Rocha ◽  
Ana Catarina Alves ◽  
Ana Margarida Medeiros ◽  
Vânia Francisco ◽  
...  

Medicina ◽  
2017 ◽  
Vol 53 (1) ◽  
pp. 19-25 ◽  
Author(s):  
Gediminas Račkauskas ◽  
Vytautas Zabiela ◽  
Germanas Marinskis ◽  
Arvydas Baranauskas ◽  
Deimilė Balkutė ◽  
...  

Cephalalgia ◽  
2009 ◽  
Vol 29 (3) ◽  
pp. 322-330 ◽  
Author(s):  
EA Wames-van der Heijden ◽  
CC Tijssen ◽  
ACG Egberts

Treatment patterns in migraine patients with cardiovascular risk factors are largely unknown. A retrospective observational study was conducted to characterize the baseline cardiovascular risk profile of new users of specific abortive migraine drugs, and to investigate treatment choices and patterns in patients with and without a known cardiovascular risk profile. New users of a triptan, ergotamine or Migrafin® ( n = 36 839) from 1 January 1990 to 31 December 2006 were included. Approximately 90 of all new users did not have a clinically recognized cardiovascular risk profile. The percentage of new users with a cardiovascular risk profile did not differ between new users of a triptan, ergotamine or Migrafin® and also did not change during the study period of 17 years. Differences in treatment choices and patterns between migraine patients with and without a known cardiovascular risk profile reveal a certain reticence in prescribing vasoconstrictive antimigraine drugs to patients at cardiovascular risk.


Sign in / Sign up

Export Citation Format

Share Document